Relief Therapeutics Holdings AG (NASDAQ:RLFTF)

BRIEF

published on 03/27/2024 at 07:05, 7 months 25 days ago

RELIEF THERAPEUTICS Holding SA Announces Extraordinary General Meeting for Anticipated Corporate Changes

Board Of Directors Extraordinary General Meeting Relief Therapeutics Share Capital Adjustment Corporate Law Amendments
PRESS RELEASE

published on 03/27/2024 at 07:00, 7 months 25 days ago

RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA to hold an Extraordinary General Meeting to vote on board members, share capital reduction, and compensation matters

Board Of Directors EGM Extraordinary General Meeting RELIEF THERAPEUTICS Holding SA Swiss Corporate Law
BRIEF

published on 03/22/2024 at 07:05, 7 months 30 days ago

Relief Therapeutics Forms Exclusive Agreement with Eton Pharmaceuticals for PKU GOLIKE in the U.S.

Relief Therapeutics Eton Pharmaceuticals PKU GOLIKE Biopharmaceutical Partnership Rare Metabolic Diseases
PRESS RELEASE

published on 03/22/2024 at 07:00, 7 months 30 days ago

Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
Relief Therapeutics enters into exclusive U.S. license and supply agreement with Eton Pharmaceuticals for PKU GOLIKE. Partnership aims to increase awareness and adoption of PKU medical formula

Metabolic Diseases Relief Therapeutics Eton Pharmaceuticals PKU GOLIKE Exclusive License
PRESS RELEASE

published on 02/28/2024 at 06:45, 8 months 22 days ago

Relief Therapeutics Renews CHF 50 million Share Subscription Facility
Relief Therapeutics renews CHF 50 million Share Subscription Facility with GEM for 3 years, advancing strategic transformation. Corporate update includes new interim CEO and operational efficiency plans

Biopharmaceutical Company Relief Therapeutics GEM Global Yield Share Subscription Facility Strategic Transformation
BRIEF

published on 02/28/2024 at 06:45, 8 months 22 days ago

Relief Therapeutics announces the renewal of a CHF 50 million share subscription agreement

Biopharmaceutical Relief Therapeutics GEM Global Yield Share Subscription Agreement Financial Investment
PRESS RELEASE

published on 10/10/2023 at 07:00, 1 year 1 month ago

Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone
PRESS RELEASE

published on 09/15/2023 at 07:00, 1 year 2 months ago

Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update
PRESS RELEASE

published on 09/01/2023 at 07:45, 1 year 2 months ago

Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
PRESS RELEASE

published on 08/30/2023 at 22:20, 1 year 2 months ago

Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics

Published on 11/21/2024 at 16:30, 44 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 13 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 14 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 1 hour 14 minutes ago

Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 16:00, 1 hour 14 minutes ago

Isaac Ullatil Joins Wellstack Board of Directors

View all ACCESSWIRE

Published on 11/21/2024 at 16:00, 1 hour 14 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 1 hour 32 minutes ago

Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 1 hour 50 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 1 hour 51 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 1 hour 52 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc

View all EQS

Published on 11/21/2024 at 06:58, 10 hours 16 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 21 hours 54 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 23 hours 29 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 23 hours 29 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 9 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE

News